Phase I, Multiple Dose Study of MLN0002 in Patients with Ulcerative Colitis
Latest Information Update: 14 Sep 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Takeda
- 07 Sep 2018 Results published in the Journal of Clinical Pharmacology
- 24 May 2016 New trial record